The state of New York currently has 14 active clinical trials seeking participants for Amyotrophic Lateral Sclerosis research studies. These trials are conducted in various cities, including New York, Rochester, Bronx and Buffalo.
Exploratory Evaluation of [11C]MPC6827
Recruiting
This is a phase 0 study that will enable an assessment of biodistribution and estimation of absorbed dose in humans based on data collected from five healthy volunteers, which is typically the minimum number required by the FDA for first-in-human studies to assess dosimetry of a new tracer. The evaluation of the brain imaging of thirty additional subjects in the 2nd part of the study will lead to a descriptive assessment of the targeting and pharmacokinetics of MPC6827 in the brain and between n... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/24/2023
Locations: Cuimc / Nyp, New York, New York
Conditions: Neurodegenerative Diseases, Alzheimer Disease, Amyotrophic Lateral Sclerosis
Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)
Recruiting
This study is a multi-center, open-label study of intravenous (IV) ANX005 in participants with ALS.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/23/2023
Locations: Annexon Investigational Site 06, New York, New York
Conditions: Amyotrophic Lateral Sclerosis